Vaxil Bio Ltd (VXL) — Cash Flow Quality Index

Latest as of June 2025: -1.24x

Vaxil Bio Ltd (VXL) has a Cash Flow Quality Index of -1.24x as of June 2025. Operating cash flow of CA$-52.00K is below net income of CA$42.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Vaxil Bio Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-1.24x

Operating CF / Net Income

Operating Cash Flow

CA$-52.00K

CAD

Net Income

CA$42.00K

CAD

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for Vaxil Bio Ltd (None–None)

Year-by-year earnings quality comparison for Vaxil Bio Ltd. For live market cap and the full company financial profile, see Vaxil Bio Ltd (VXL) total market value.

Year	Quality Index	Operating CF (CAD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.